SMPD1 rs121907954: What Your Genotype Means
The rs121907954 variant is a specific change in the SMPD1 gene, often referred to as p.Arg498Leu or R496L. It is recognized as a pathogenic variant associated with Niemann-Pick disease type A and B, particularly within the Ashkenazi Jewish population.
What each genotype means
Typical SMPD1 genotype
This genotype represents the common, non-pathogenic sequence at this position in the SMPD1 gene. It is not associated with the specific Niemann-Pick disease type A/B risk variant described in this catalog.
This is the most common genotype found in the general population across all ancestries.
Carrier of Niemann-Pick variant
This genotype indicates you carry one copy of the p.Arg498Leu (R496L) variant, which is a known pathogenic mutation in the SMPD1 gene. Carriers are typically asymptomatic, but because Niemann-Pick disease type A/B is an autosomal recessive condition, you should discuss the implications for family planning and potential carrier testing for your partner with a genetic counselor or clinician.
This variant is a known founder mutation in the Ashkenazi Jewish population, where the carrier frequency is approximately 1 in 90 to 1 in 100.
Increased risk for ASMD
This genotype indicates you carry two copies of the p.Arg498Leu (R496L) variant. This variant is associated with Acid Sphingomyelinase Deficiency (ASMD), also known as Niemann-Pick disease type A or B. Please consult with a medical geneticist or specialist to discuss clinical evaluation, as this genotype is linked to the potential for lysosomal storage disease symptoms.
This homozygous genotype is very rare in the general population and is primarily observed in individuals affected by or at high risk for Niemann-Pick disease.
Understanding the SMPD1 Gene
The SMPD1 gene provides instructions for producing an enzyme called acid sphingomyelinase. This enzyme is essential for the proper function of lysosomes, which are the recycling centers of the cell. Acid sphingomyelinase is responsible for breaking down a fatty substance called sphingomyelin into ceramide. When the SMPD1 gene contains certain mutations, the body may not produce enough of this enzyme, or the enzyme may not function correctly. This leads to the accumulation of sphingomyelin within cells, which can eventually cause the cells to malfunction and die. This process is the underlying cause of Niemann-Pick disease types A and B, which are now collectively referred to as acid sphingomyelinase deficiency (ASMD). The severity of the condition often depends on how much residual enzyme activity remains.
What is the rs121907954 Variant?
The variant rs121907954 represents a specific DNA change in the SMPD1 gene, resulting in an amino acid substitution where arginine is replaced by leucine at position 498 (p.Arg498Leu). In some literature, this is also noted as R496L. This variant is classified as pathogenic, meaning it is known to disrupt the normal function of the acid sphingomyelinase enzyme. Because Niemann-Pick disease is an autosomal recessive condition, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the disease. Individuals who carry only one copy of this variant are generally considered carriers. Carriers typically do not show symptoms of the disease but can pass the variant on to their children. Understanding this variant is particularly important for carrier screening programs, especially in populations where this specific mutation is more prevalent.
Research and Clinical Significance
Research has established a strong association between specific SMPD1 mutations and Niemann-Pick disease. The rs121907954 variant is one of three common mutations that account for the vast majority of Niemann-Pick disease type A cases in the Ashkenazi Jewish population. While the evidence linking this variant to the disease is well-documented in clinical genetics, it is important to note that the clinical presentation can vary. Some individuals with certain SMPD1 mutations may develop the severe, infantile-onset type A, while others may develop the more chronic, visceral type B. The classification between these types is often viewed as a continuum rather than two distinct categories. Because this is a recessive condition, the presence of this variant in a single copy does not cause the disease, but it does indicate carrier status, which is relevant for family planning and genetic counseling.
Population Frequency and Context
The frequency of the rs121907954 variant varies significantly across different ethnic groups. It is most notably recognized as a founder mutation within the Ashkenazi Jewish population. In this group, the carrier frequency for Niemann-Pick disease is estimated to be approximately 1 in 90 to 1 in 100. Because of this higher prevalence, carrier screening for this and other common SMPD1 mutations is often recommended for individuals of Ashkenazi Jewish descent. In other populations, the prevalence of this specific variant is much lower, and other mutations may be more common. It is essential to interpret these statistics in the context of one's own ancestry and family history. Genetic testing results should always be discussed with a qualified healthcare provider or a genetic counselor who can provide personalized context based on your specific situation.
Managing Your Genetic Information
If you have received information about your status regarding the rs121907954 variant, it is important to understand what this means for you and your family. Being a carrier of a recessive condition is common, and most people carry several such variants without ever knowing it. If you are a carrier, it simply means you have one copy of the variant and one functional copy of the gene. This information is most useful for reproductive planning. If you are concerned about your results or your family history, the best course of action is to consult with a genetic counselor. They can help you understand the implications of your genotype, discuss the risks for future children, and explain the options for further testing if necessary. Never use genetic information to make medical decisions without professional guidance, and always rely on clinical testing rather than direct-to-consumer reports for medical diagnosis.
How common is this variant?
The rs121907954 variant is a known founder mutation in the Ashkenazi Jewish population, where the carrier frequency for Niemann-Pick disease is approximately 1 in 90 to 1 in 100.
Frequently asked questions
What is Niemann-Pick disease?
Niemann-Pick disease is a group of inherited lysosomal storage disorders caused by the inability of the body to properly break down fats like sphingomyelin. This leads to the accumulation of these fats in various organs, causing symptoms like enlargement of the liver and spleen.
Does having one copy of the rs121907954 variant mean I have the disease?
No, Niemann-Pick disease is an autosomal recessive condition. This means that typically, an individual must inherit two copies of a pathogenic variant—one from each parent—to be affected by the disease.
Should I get tested for this variant?
Carrier screening is often recommended for individuals of Ashkenazi Jewish descent due to the higher prevalence of this variant in that population. You should discuss the benefits and limitations of genetic testing with your doctor or a genetic counselor.
Is there a cure for Niemann-Pick disease?
Currently, there is no cure for Niemann-Pick disease, and treatment is primarily focused on managing symptoms and providing supportive care. Research into enzyme replacement therapies and other treatments is ongoing.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121907954?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SMPD1
Pathogenic missense variant (p.Arg498Leu) associated with Niemann-Pick disease types A and B.
Pathogenic missense variant (p.Leu304Pro) associated with Niemann-Pick disease types A and B.
Pathogenic missense variant in SMPD1 (p.Arg498Leu) causing severe infantile Niemann-Pick disease type A in homozygous or compound heterozygous individuals.
Single-nucleotide deletion (c.996delC) leading to acid sphingomyelinase deficiency.
A missense variant (c.1493G>A, p.Arg498Leu) in acid sphingomyelinase conferring carrier status for Niemann-Pick disease types A and B.
Pathogenic missense variant (p.Arg498Leu) causing acid sphingomyelinase deficiency (Niemann-Pick disease type A/B).